UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Phase I and pharmacokinetic study of taxotere (RP 56976) administered as a 24-hour infusion

Cancer research (Chicago, Ill.), 1993-02, Vol.53 (3), p.523-527

1993

Volltextzugriff (PDF)

Multicentre phase II pharmacological evaluation of rhizoxin

British journal of cancer, 1996-12, Vol.74 (12), p.1944-1948

1996

Volltextzugriff (PDF)

Phase I pharmacokinetics and limited sampling strategies for the bioreductive alkylating drug EO9

European journal of cancer (1990), 1996-08, Vol.32 (9), p.1518-1522

1996

Volltextzugriff (PDF)

Phase I and pharmacokinetic study of rhizoxin

Cancer research (Chicago, Ill.), 1992-05, Vol.52 (10), p.2894-2898

1992

Volltextzugriff (PDF)

Identification of a multidrug resistance modulator with clinical potential by analysis of synergistic activity in vitro, toxicity in vivo and growth delay in a solid human tumour xenograft

Biochemical pharmacology, 1994-01, Vol.47 (2), p.257-266

1994

Volltextzugriff (PDF)

Multicentre phase II pharmacological evaluation of rhizoxin. Eortc early clinical studies (ECSG)/pharmacology and molecular mechanisms (PAMM) groups

British journal of cancer, 1996-12, Vol.74 (12), p.1944-1948

1996

Volltextzugriff (PDF)

A pharmacokinetic comparison of intravenous versus intra-arterial folinic acid

British journal of cancer, 1992-01, Vol.65 (1), p.133-135

1992

Volltextzugriff (PDF)

Phase I and pharmacokinetic study of LM985 (flavone acetic acid ester)

Cancer research (Chicago, Ill.), 1986-06, Vol.46 (6), p.3142-3146

1986

Volltextzugriff (PDF)

Formulation of 1,3,5-triglycidyl-S-triazinetrione (α-TGT) for intravenous injection

International journal of pharmaceutics, 1982-01, Vol.10 (2), p.109-118

1982

Volltextzugriff (PDF)

The analysis and animal pharmacokinetics of 1,2,4, triglycidyl urazol using a high-pressure liquid chromatographic technique

Cancer chemotherapy and pharmacology, 1984-01, Vol.12 (3), p.198-200

1984

Volltextzugriff (PDF)

Phase I pharmacokinetics and limited sampling strategies for the bioreductive alkylating drug EO9. EORTC Early Clinical Trials Group

European journal of cancer (1990), 1996-08, Vol.32A (9), p.1518-1522

1996

Volltextzugriff (PDF)

Phase I and pharmacokinetic study of flavone acetic acid

Cancer research (Chicago, Ill.), 1987-12, Vol.47 (24), p.6776-6781

1987

Volltextzugriff (PDF)

Prelinical and Phase I Studies With Rhizoxin to Apply a Pharmacokinetically Guided Dose-Escalation Scheme

JNCI : Journal of the National Cancer Institute, 1992-04, Vol.84 (7), p.494-500

1992

Volltextzugriff (PDF)

Preclinical and phase I studies with rhizoxin to apply a pharmacokinetically guided dose-escalation scheme

JNCI : Journal of the National Cancer Institute, 1992-04, Vol.84 (7), p.494-500

1992

Volltextzugriff (PDF)

A clinical and pharmacokinetic phase I study of 1,2,4-triglycidylurazol (TGU, NSC 332488)

European journal of cancer & clinical oncology, 1986-11, Vol.22 (11), p.1325-1329

1986

Volltextzugriff (PDF)

Phase I clinical study of LL-D49194α1 with retrospective pharmacokinetic investigations in mice and humans

Cancer chemotherapy and pharmacology, 1993-09, Vol.31 (5), p.395-400

1993

Volltextzugriff (PDF)

Phase I clinical study of LL-D49194 alpha 1 with retrospective pharmacokinetic investigations in mice and humans. The EORTC ECTG

Cancer chemotherapy and pharmacology, 1993, Vol.31 (5), p.395

1993

Volltextzugriff (PDF)

Could interspecies differences in the protein binding of flavone acetic acid contribute to the failure to predict lack of efficacy in patients?

Cancer chemotherapy and pharmacology, 1989-01, Vol.23 (6), p.397-400

1989

Volltextzugriff (PDF)

Flavone acetic acid: a nonlinear pharmacokinetic model

Cancer chemotherapy and pharmacology, 1988-01, Vol.22 (2), p.114-119

1988

Volltextzugriff (PDF)

Phase I clinical and pharmacokinetic study of LY 195448

Cancer chemotherapy and pharmacology, 1989-01, Vol.24 (4), p.233-237

1989

Volltextzugriff (PDF)

Solriamfetol Real World Experience Study: Initiation, Titration, Safety, Effectiveness, and Experience During Follow-Up for Patients with Narcolepsy from Germany (P4-13.006)

Neurology, 2023-04, Vol.100 (17_supplement_2)

2023

Volltextzugriff (PDF)

039 Solriamfetol real world experience study (SURWEY): safety and effectiveness for patients with narcolepsy from Germany

Journal of neurology, neurosurgery and psychiatry, 2022-09, Vol.93 (9), p.e2.234

2022

Volltextzugriff (PDF)

Solriamfetol real world experience study (SURWEY): Initiation, titration, safety, effectiveness, and experience during follow-up for patients with narcolepsy from Germany

Sleep medicine, 2023-03, Vol.103, p.138-143

2023

Volltextzugriff (PDF)

Phase I and Pharmacodynamic Trial of the DNA Methyltransferase Inhibitor Decitabine and Carboplatin in Solid Tumors

Journal of clinical oncology, 2007-10, Vol.25 (29), p.4603-4609

2007

Volltextzugriff (PDF)

Solriamfetol Real World Experience Study (SURWEY): Safety, Effectiveness, and Experience During Follow-Up for Patients with Narcolepsy from Germany

Sleep medicine, 2022-12, Vol.100, p.S166-S167

2022

Volltextzugriff (PDF)

1 – 25 von 27

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(26)
Mit Volltextzugriff
(25)

Publikationsform

Artikel
(27)

Sprache

Englisch
(27)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Phase I and pharmacokinetic study of taxotere (RP 56976) administered as a 24-hour infusion

Multicentre phase II pharmacological evaluation of rhizoxin

Phase I pharmacokinetics and limited sampling strategies for the bioreductive alkylating drug EO9

Phase I and pharmacokinetic study of rhizoxin

Identification of a multidrug resistance modulator with clinical potential by analysis of synergistic activity in vitro, toxicity in vivo and growth delay in a solid human tumour xenograft

Multicentre phase II pharmacological evaluation of rhizoxin. Eortc early clinical studies (ECSG)/pharmacology and molecular mechanisms (PAMM) groups

A pharmacokinetic comparison of intravenous versus intra-arterial folinic acid

Phase I and pharmacokinetic study of LM985 (flavone acetic acid ester)

Formulation of 1,3,5-triglycidyl-S-triazinetrione (α-TGT) for intravenous injection

The analysis and animal pharmacokinetics of 1,2,4, triglycidyl urazol using a high-pressure liquid chromatographic technique

Phase I pharmacokinetics and limited sampling strategies for the bioreductive alkylating drug EO9. EORTC Early Clinical Trials Group

Phase I and pharmacokinetic study of flavone acetic acid

Prelinical and Phase I Studies With Rhizoxin to Apply a Pharmacokinetically Guided Dose-Escalation Scheme

Preclinical and phase I studies with rhizoxin to apply a pharmacokinetically guided dose-escalation scheme

A clinical and pharmacokinetic phase I study of 1,2,4-triglycidylurazol (TGU, NSC 332488)

Phase I clinical study of LL-D49194α1 with retrospective pharmacokinetic investigations in mice and humans

Phase I clinical study of LL-D49194 alpha 1 with retrospective pharmacokinetic investigations in mice and humans. The EORTC ECTG

Could interspecies differences in the protein binding of flavone acetic acid contribute to the failure to predict lack of efficacy in patients?

Flavone acetic acid: a nonlinear pharmacokinetic model

Phase I clinical and pharmacokinetic study of LY 195448

Solriamfetol Real World Experience Study: Initiation, Titration, Safety, Effectiveness, and Experience During Follow-Up for Patients with Narcolepsy from Germany (P4-13.006)

039 Solriamfetol real world experience study (SURWEY): safety and effectiveness for patients with narcolepsy from Germany

Solriamfetol real world experience study (SURWEY): Initiation, titration, safety, effectiveness, and experience during follow-up for patients with narcolepsy from Germany

Phase I and Pharmacodynamic Trial of the DNA Methyltransferase Inhibitor Decitabine and Carboplatin in Solid Tumors

Solriamfetol Real World Experience Study (SURWEY): Safety, Effectiveness, and Experience During Follow-Up for Patients with Narcolepsy from Germany

Suchergebnisse filtern